scholarly journals Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial

2008 ◽  
Vol 5 (4) ◽  
pp. 61-62
Author(s):  

Sign in / Sign up

Export Citation Format

Share Document